| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |